Outstanding bonds - Smiths Group plc

Cookies

The cookie settings on this website are set to ‘allow all cookies’. Leaving your settings to ‘allow all cookies’ means you consent to a website remembering your preferences and generally enhancing the user experience. If you prefer a website to not remember your preferences, you can change your settings at any time by changing the privacy settings of your browser.

Find out more about cookies >

Outstanding bonds

The Group's strategy is to finance its balance sheet primarily from the rated long-term public US, UK and European capital markets to maintain a diversified investor profile and a balanced long-term maturity profile and pro-actively refinance maturities as they fall due.

Debt instruments at 31.7.17
  £ millions
$175m 7.37% private placement 2018 133
$250m 7.20% senior notes 2019 189
$400m 3.625% senior notes 2022 301
€600m 1.25% eurobonds 2023 533
€650m 2.0% eurobonds 2027 574
Debt instruments 1,730
 
Interest accrual 16
Other indebtedness 3
Gross debt 1,749
 
Liquid resources (782)
 
Net debt 967
 
Net assets 2,638





back to top

Smiths Group divisions:

John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, Flex-Tek

Smiths Group plc:
Registered office 4th Floor, 11-12 St James’s Square, London, SW1Y 4LB
Incorporated in England No. 137013
Copyright 2017 Smiths Group plc.
All rights Reserved | Legal Notice | Privacy Policy | Cookie Policy